SITE001-0078

SITE001 (USA) › SITE001-0078

SITE001-0078

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE001 (USA) · Dr. Reyes
consented 2025-12-02

enrolled

AEs

4

Serious

0

Dropout signal

–

Adverse events

4

Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-07-24 (study day 49); relationship: not assessed

moderate assessed

Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-07-19 (study day 44); relationship: NOT RELATED

moderate assessed

Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-07-14 (study day 39); relationship: NOT RELATED

moderate assessed

Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-06-19 (study day 14); relationship: not assessed

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.